UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity

Rheumatology (Oxford, England), 2020-08, Vol.59 (8), p.2109-2114

2020

Volltextzugriff (PDF)

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset

Rheumatology (Oxford, England), 2014-12, Vol.53 (12), p.2204-2208

2014

Volltextzugriff (PDF)

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis

Arthritis research & therapy, 2011-01, Vol.13 (2), p.209-209

2011

Volltextzugriff (PDF)

The EuroMyositis registry: an international collaborative tool to facilitate myositis research

Annals of the rheumatic diseases, 2018-01, Vol.77 (1), p.30-39

2018

Volltextzugriff (PDF)

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

Rheumatology (Oxford, England), 2009-06, Vol.48 (6), p.607-612

2009

Volltextzugriff (PDF)

Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies

Frontiers in immunology, 2019-04, Vol.10, p.848-848

2019

Volltextzugriff (PDF)

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

Arthritis research & therapy, 2014-07, Vol.16 (4), p.R138-R138, Article R138

2014

Volltextzugriff (PDF)

Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort

Journal of autoimmunity, 2017-11, Vol.84, p.55-64

2017

Volltextzugriff (PDF)

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort

Rheumatology (Oxford, England), 2019-03, Vol.58 (3), p.468-475

2019

Volltextzugriff (PDF)

The diagnostic utility of autoantibodies in adult and juvenile myositis

Current opinion in rheumatology, 2013-11, Vol.25 (6), p.772-777

2013

Volltextzugriff (PDF)

Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis

Rheumatology (Oxford, England), 2018-04, Vol.57 (4), p.712-717

2018

Volltextzugriff (PDF)

The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis

Rheumatology (Oxford, England), 2019-04, Vol.58 (4), p.650-655

2019

Volltextzugriff (PDF)

Antinuclear antibodies and clinical associations in a british cohort with limited cutaneous systemic sclerosis

Journal of rheumatology, 2011-04, Vol.38 (4), p.702-705

2011

Volltextzugriff (PDF)

Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies

Arthritis research & therapy, 2016-07, Vol.18 (1), p.156-156, Article 156

2016

Volltextzugriff (PDF)

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer

Arthritis research & therapy, 2018-08, Vol.20 (1), p.176-176, Article 176

2018

Volltextzugriff (PDF)

Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with “idiopathic” interstitial lung disease

Clinical immunology (Orlando, Fla.), 2024-05, Vol.262, p.110201-110201, Article 110201

2024

Volltextzugriff (PDF)

Brief Report: Anti–Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2016-11, Vol.68 (11), p.2778-2783

2016

Volltextzugriff (PDF)

Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis: Reply

Rheumatology (Oxford, England), 2019-11, Vol.58 (11), p.2073-2074

2019

Volltextzugriff (PDF)

Arthritis in idiopathic inflammatory myopathy: clinical features and autoantibody associations

Journal of rheumatology, 2014-06, Vol.41 (6), p.1133-1139

2014

Volltextzugriff (PDF)

Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis

Current opinion in rheumatology, 2008-11, Vol.20 (6), p.675-680

2008

Volltextzugriff (PDF)

Pathogenic mechanisms of disease in myositis: autoantigens as clues

Current opinion in rheumatology, 2009-11, Vol.21 (6), p.604-609

2009

Volltextzugriff (PDF)

Identification of a novel autoantibody directed against small ubiquitin‐like modifier activating enzyme in dermatomyositis

Arthritis and rheumatism, 2007-09, Vol.56 (9), p.3132-3137

2007

Volltextzugriff (PDF)

Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients

Orvosi hetilap, 2015-09, Vol.156 (36), p.1451

2015

Volltextzugriff (PDF)

220 Discrepancy between solid-phase immunoassays and immunoprecipitation in detecting anti-TIF1 gamma in patients with myositis

Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)

2019

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(54)
Ungarisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis

The EuroMyositis registry: an international collaborative tool to facilitate myositis research

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort

The diagnostic utility of autoantibodies in adult and juvenile myositis

Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis

The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis

Antinuclear antibodies and clinical associations in a british cohort with limited cutaneous systemic sclerosis

Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer

Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with “idiopathic” interstitial lung disease

Brief Report: Anti–Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis

Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis: Reply

Arthritis in idiopathic inflammatory myopathy: clinical features and autoantibody associations

Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis

Pathogenic mechanisms of disease in myositis: autoantigens as clues

Identification of a novel autoantibody directed against small ubiquitin‐like modifier activating enzyme in dermatomyositis

Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients

220 Discrepancy between solid-phase immunoassays and immunoprecipitation in detecting anti-TIF1 gamma in patients with myositis

Suchergebnisse filtern